Kuppam hosp gets AP's first digital nerve centre
2
Tirupati: In a landmark development for healthcare, the first-ever digital nerve centre was inaugurated today at Kuppam Area Hospital by chief minister
N Chandrababu Naidu
. This facility aims to integrate patient medical records across hospitals and primary healthcare centres, marking a pioneering step in the state's digital health initiative.
Supported by the Gates Foundation, the Tata Digi Nerve Centre in Kuppam serves as a pilot project connecting 13 primary healthcare centres (PHCs) virtually. Alongside health minister Satyakumar Yadav, the CM linked these PHCs to the centre and directed health officials to expand services.
Addressing the public, Naidu said, "In phase two, all PHCs in Chittoor district will be integrated, followed by a statewide rollout.
We plan to digitize health histories and enhance medical services by coordinating Ayushman Bharat with the NTR Vaidya Seva scheme. The Digital Nerve Centre in Kuppam will serve as a global model, incorporating advanced technologies like Artificial Intelligence. It should also connect with ANMs and Anganwadis.
"
The CM stressed using technology to reduce healthcare costs, currently Rs 19,000 crore, through data-driven medicine provision, preventive health, and real-time monitoring using cost-effective wearables.
Mobile medical units will conduct quarterly blood tests, and health monitoring of pregnant women will be prioritised.
The centre links Kuppam Area Hospital with 13 PHCs and 92 Village Health Centres, offering integrated services such as continuous health monitoring, timely diagnosis, specialist consultations, and coordination with government schemes and private hospitals.
Initially implemented in Kuppam, the programme will expand to Chittoor district and eventually across the state.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
22 minutes ago
- New Indian Express
Uttarakhand sacks 234 doctors for bond violation, prolonged absence; recovery proceedings initiated
DEHRADUN: The Uttarakhand government has dismissed 234 doctors for prolonged absenteeism and blatant violation of their bond agreements. The action has sent shockwaves through the state's health department, which is also poised to initiate recovery proceedings against these bond-bound doctors. The Health Department has already begun the process of forwarding the list of these 234 doctors to the National Medical Council. Officials estimate that a staggering sum of up to Rs 2 crore could be recovered from the doctors as part of their bond obligations. Uttarakhand Health Minister Dr. Dhan Singh Rawat weighed in on the drastic step. "Many doctors completed their MBBS studies in the state at subsidized fees but subsequently violated the terms of their bond agreements," Rawat told TNIE. "Around 234 such doctors have been identified. These doctors have reportedly been absent from duty for extended periods without any official notification, leading to their dismissal." Rawat further elaborated on the terms of the agreement. "As per the agreement with their respective medical colleges, these doctors were mandated to serve in the state's hilly districts for a minimum of five years upon graduating with their MBBS," he explained. "The bond stipulated that failure to comply would require them to deposit a pre-determined sum and obtain a No Objection Certificate before pursuing opportunities outside the state or entering private practice." "Despite these clear terms, 234 doctors assigned to the state's remote mountainous regions have remained absent from their posts without authorisation. This constitutes a clear breach of bond conditions and an act of gross indiscipline," the minister said.
Deccan Herald
2 hours ago
- Deccan Herald
Opposition protests in Kerala demand Veena George's resignation
Opposition Congress-led UDF demanded that the government should give financial assistance of Rs 25 lakh, job to the deceased woman's daughter who is a nursing student and meet the treatment expenses of the daughter who was under treatment at the medical college hospital.
Business Standard
4 hours ago
- Business Standard
Lupin launches generic version of anticholinergic medication Ipratropium bromide in United States
Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States. Ipratropium Bromide Nasal Solution is a bioequivalent to Atrovent Nasal Sprayof Boehringer Ingelheim Pharmaceuticals, Inc. The solution is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children aged 6 years and older. According to IQVIA MAT May 2025, Ipratropium Bromide Nasal Solution (RLD Atrovent) had estimated annual sales of $63 million in the U.S. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. The companys consolidated net profit surged 114.9% to Rs 772.52 crore on a 13.6% jump in net sales to Rs 5,562.20 crore in Q4 FY25 over Q4 FY24. The scrip added 1.36% to end at Rs 1982.20 on the BSE today.
